Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Gabapentin Drug market report explains the definition, types, applications, major countries, and major players of the Gabapentin Drug market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Jiangsu Hengrui Medicine
Depomed
Sciegen Pharmaceuticals
Glenmark
Taro
Pfizer
Teva
Amneal Pharmaceuticals
Sun Pharmaceutical
Aurobindo Pharma
Tris Pharma
Epic Pharma
Lupin Limited
Acella Pharmaceuticals
Marksans Pharma
ACI HealthCare Limited
InvaGen Pharmaceuticals
CSPC Ouyi Pharmaceutical
Apotex
Alkem Laboratories
Mylan
Zydus Pharmaceuticals
Hi-Tech Pharmaceuticals
By Type:
Capsule
Tablet
Oral solution
By End-User:
Postherpetic neuralgia in adults
Partial onset seizures
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Gabapentin Drug Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Gabapentin Drug Outlook to 2028- Original Forecasts
-
2.2 Gabapentin Drug Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Gabapentin Drug Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Gabapentin Drug Market- Recent Developments
-
6.1 Gabapentin Drug Market News and Developments
-
6.2 Gabapentin Drug Market Deals Landscape
7 Gabapentin Drug Raw Materials and Cost Structure Analysis
-
7.1 Gabapentin Drug Key Raw Materials
-
7.2 Gabapentin Drug Price Trend of Key Raw Materials
-
7.3 Gabapentin Drug Key Suppliers of Raw Materials
-
7.4 Gabapentin Drug Market Concentration Rate of Raw Materials
-
7.5 Gabapentin Drug Cost Structure Analysis
-
7.5.1 Gabapentin Drug Raw Materials Analysis
-
7.5.2 Gabapentin Drug Labor Cost Analysis
-
7.5.3 Gabapentin Drug Manufacturing Expenses Analysis
8 Global Gabapentin Drug Import and Export Analysis (Top 10 Countries)
-
8.1 Global Gabapentin Drug Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Gabapentin Drug Export by Region (Top 10 Countries) (2017-2028)
9 Global Gabapentin Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Gabapentin Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Capsule Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Tablet Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Oral solution Consumption and Growth Rate (2017-2022)
-
9.2 Global Gabapentin Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Postherpetic neuralgia in adults Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Partial onset seizures Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Gabapentin Drug Market Analysis and Outlook till 2022
-
10.1 Global Gabapentin Drug Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Gabapentin Drug Consumption (2017-2022)
-
10.2.2 Canada Gabapentin Drug Consumption (2017-2022)
-
10.2.3 Mexico Gabapentin Drug Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Gabapentin Drug Consumption (2017-2022)
-
10.3.2 UK Gabapentin Drug Consumption (2017-2022)
-
10.3.3 Spain Gabapentin Drug Consumption (2017-2022)
-
10.3.4 Belgium Gabapentin Drug Consumption (2017-2022)
-
10.3.5 France Gabapentin Drug Consumption (2017-2022)
-
10.3.6 Italy Gabapentin Drug Consumption (2017-2022)
-
10.3.7 Denmark Gabapentin Drug Consumption (2017-2022)
-
10.3.8 Finland Gabapentin Drug Consumption (2017-2022)
-
10.3.9 Norway Gabapentin Drug Consumption (2017-2022)
-
10.3.10 Sweden Gabapentin Drug Consumption (2017-2022)
-
10.3.11 Poland Gabapentin Drug Consumption (2017-2022)
-
10.3.12 Russia Gabapentin Drug Consumption (2017-2022)
-
10.3.13 Turkey Gabapentin Drug Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Gabapentin Drug Consumption (2017-2022)
-
10.4.2 Japan Gabapentin Drug Consumption (2017-2022)
-
10.4.3 India Gabapentin Drug Consumption (2017-2022)
-
10.4.4 South Korea Gabapentin Drug Consumption (2017-2022)
-
10.4.5 Pakistan Gabapentin Drug Consumption (2017-2022)
-
10.4.6 Bangladesh Gabapentin Drug Consumption (2017-2022)
-
10.4.7 Indonesia Gabapentin Drug Consumption (2017-2022)
-
10.4.8 Thailand Gabapentin Drug Consumption (2017-2022)
-
10.4.9 Singapore Gabapentin Drug Consumption (2017-2022)
-
10.4.10 Malaysia Gabapentin Drug Consumption (2017-2022)
-
10.4.11 Philippines Gabapentin Drug Consumption (2017-2022)
-
10.4.12 Vietnam Gabapentin Drug Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Gabapentin Drug Consumption (2017-2022)
-
10.5.2 Colombia Gabapentin Drug Consumption (2017-2022)
-
10.5.3 Chile Gabapentin Drug Consumption (2017-2022)
-
10.5.4 Argentina Gabapentin Drug Consumption (2017-2022)
-
10.5.5 Venezuela Gabapentin Drug Consumption (2017-2022)
-
10.5.6 Peru Gabapentin Drug Consumption (2017-2022)
-
10.5.7 Puerto Rico Gabapentin Drug Consumption (2017-2022)
-
10.5.8 Ecuador Gabapentin Drug Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Gabapentin Drug Consumption (2017-2022)
-
10.6.2 Kuwait Gabapentin Drug Consumption (2017-2022)
-
10.6.3 Oman Gabapentin Drug Consumption (2017-2022)
-
10.6.4 Qatar Gabapentin Drug Consumption (2017-2022)
-
10.6.5 Saudi Arabia Gabapentin Drug Consumption (2017-2022)
-
10.6.6 United Arab Emirates Gabapentin Drug Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Gabapentin Drug Consumption (2017-2022)
-
10.7.2 South Africa Gabapentin Drug Consumption (2017-2022)
-
10.7.3 Egypt Gabapentin Drug Consumption (2017-2022)
-
10.7.4 Algeria Gabapentin Drug Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Gabapentin Drug Consumption (2017-2022)
-
10.8.2 New Zealand Gabapentin Drug Consumption (2017-2022)
11 Global Gabapentin Drug Competitive Analysis
-
11.1 Jiangsu Hengrui Medicine
-
11.1.1 Jiangsu Hengrui Medicine Company Details
-
11.1.2 Jiangsu Hengrui Medicine Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Jiangsu Hengrui Medicine Gabapentin Drug Main Business and Markets Served
-
11.1.4 Jiangsu Hengrui Medicine Gabapentin Drug Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Depomed
-
11.2.1 Depomed Company Details
-
11.2.2 Depomed Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Depomed Gabapentin Drug Main Business and Markets Served
-
11.2.4 Depomed Gabapentin Drug Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Sciegen Pharmaceuticals
-
11.3.1 Sciegen Pharmaceuticals Company Details
-
11.3.2 Sciegen Pharmaceuticals Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Sciegen Pharmaceuticals Gabapentin Drug Main Business and Markets Served
-
11.3.4 Sciegen Pharmaceuticals Gabapentin Drug Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Glenmark
-
11.4.1 Glenmark Company Details
-
11.4.2 Glenmark Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Glenmark Gabapentin Drug Main Business and Markets Served
-
11.4.4 Glenmark Gabapentin Drug Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Taro
-
11.5.1 Taro Company Details
-
11.5.2 Taro Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Taro Gabapentin Drug Main Business and Markets Served
-
11.5.4 Taro Gabapentin Drug Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Pfizer
-
11.6.1 Pfizer Company Details
-
11.6.2 Pfizer Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Pfizer Gabapentin Drug Main Business and Markets Served
-
11.6.4 Pfizer Gabapentin Drug Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Teva
-
11.7.1 Teva Company Details
-
11.7.2 Teva Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Teva Gabapentin Drug Main Business and Markets Served
-
11.7.4 Teva Gabapentin Drug Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Amneal Pharmaceuticals
-
11.8.1 Amneal Pharmaceuticals Company Details
-
11.8.2 Amneal Pharmaceuticals Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Amneal Pharmaceuticals Gabapentin Drug Main Business and Markets Served
-
11.8.4 Amneal Pharmaceuticals Gabapentin Drug Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Sun Pharmaceutical
-
11.9.1 Sun Pharmaceutical Company Details
-
11.9.2 Sun Pharmaceutical Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Sun Pharmaceutical Gabapentin Drug Main Business and Markets Served
-
11.9.4 Sun Pharmaceutical Gabapentin Drug Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Aurobindo Pharma
-
11.10.1 Aurobindo Pharma Company Details
-
11.10.2 Aurobindo Pharma Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Aurobindo Pharma Gabapentin Drug Main Business and Markets Served
-
11.10.4 Aurobindo Pharma Gabapentin Drug Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Tris Pharma
-
11.11.1 Tris Pharma Company Details
-
11.11.2 Tris Pharma Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Tris Pharma Gabapentin Drug Main Business and Markets Served
-
11.11.4 Tris Pharma Gabapentin Drug Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Epic Pharma
-
11.12.1 Epic Pharma Company Details
-
11.12.2 Epic Pharma Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Epic Pharma Gabapentin Drug Main Business and Markets Served
-
11.12.4 Epic Pharma Gabapentin Drug Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Lupin Limited
-
11.13.1 Lupin Limited Company Details
-
11.13.2 Lupin Limited Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Lupin Limited Gabapentin Drug Main Business and Markets Served
-
11.13.4 Lupin Limited Gabapentin Drug Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Acella Pharmaceuticals
-
11.14.1 Acella Pharmaceuticals Company Details
-
11.14.2 Acella Pharmaceuticals Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Acella Pharmaceuticals Gabapentin Drug Main Business and Markets Served
-
11.14.4 Acella Pharmaceuticals Gabapentin Drug Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Marksans Pharma
-
11.15.1 Marksans Pharma Company Details
-
11.15.2 Marksans Pharma Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Marksans Pharma Gabapentin Drug Main Business and Markets Served
-
11.15.4 Marksans Pharma Gabapentin Drug Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 ACI HealthCare Limited
-
11.16.1 ACI HealthCare Limited Company Details
-
11.16.2 ACI HealthCare Limited Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 ACI HealthCare Limited Gabapentin Drug Main Business and Markets Served
-
11.16.4 ACI HealthCare Limited Gabapentin Drug Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 InvaGen Pharmaceuticals
-
11.17.1 InvaGen Pharmaceuticals Company Details
-
11.17.2 InvaGen Pharmaceuticals Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 InvaGen Pharmaceuticals Gabapentin Drug Main Business and Markets Served
-
11.17.4 InvaGen Pharmaceuticals Gabapentin Drug Product Portfolio
-
11.17.5 Recent Research and Development Strategies
-
11.18 CSPC Ouyi Pharmaceutical
-
11.18.1 CSPC Ouyi Pharmaceutical Company Details
-
11.18.2 CSPC Ouyi Pharmaceutical Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.18.3 CSPC Ouyi Pharmaceutical Gabapentin Drug Main Business and Markets Served
-
11.18.4 CSPC Ouyi Pharmaceutical Gabapentin Drug Product Portfolio
-
11.18.5 Recent Research and Development Strategies
-
11.19 Apotex
-
11.19.1 Apotex Company Details
-
11.19.2 Apotex Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.19.3 Apotex Gabapentin Drug Main Business and Markets Served
-
11.19.4 Apotex Gabapentin Drug Product Portfolio
-
11.19.5 Recent Research and Development Strategies
-
11.20 Alkem Laboratories
-
11.20.1 Alkem Laboratories Company Details
-
11.20.2 Alkem Laboratories Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.20.3 Alkem Laboratories Gabapentin Drug Main Business and Markets Served
-
11.20.4 Alkem Laboratories Gabapentin Drug Product Portfolio
-
11.20.5 Recent Research and Development Strategies
-
11.21 Mylan
-
11.21.1 Mylan Company Details
-
11.21.2 Mylan Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.21.3 Mylan Gabapentin Drug Main Business and Markets Served
-
11.21.4 Mylan Gabapentin Drug Product Portfolio
-
11.21.5 Recent Research and Development Strategies
-
11.22 Zydus Pharmaceuticals
-
11.22.1 Zydus Pharmaceuticals Company Details
-
11.22.2 Zydus Pharmaceuticals Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.22.3 Zydus Pharmaceuticals Gabapentin Drug Main Business and Markets Served
-
11.22.4 Zydus Pharmaceuticals Gabapentin Drug Product Portfolio
-
11.22.5 Recent Research and Development Strategies
-
11.23 Hi-Tech Pharmaceuticals
-
11.23.1 Hi-Tech Pharmaceuticals Company Details
-
11.23.2 Hi-Tech Pharmaceuticals Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.23.3 Hi-Tech Pharmaceuticals Gabapentin Drug Main Business and Markets Served
-
11.23.4 Hi-Tech Pharmaceuticals Gabapentin Drug Product Portfolio
-
11.23.5 Recent Research and Development Strategies
12 Global Gabapentin Drug Market Outlook by Types and Applications to 2028
-
12.1 Global Gabapentin Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Capsule Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Tablet Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Oral solution Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Gabapentin Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Postherpetic neuralgia in adults Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Partial onset seizures Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Gabapentin Drug Market Analysis and Outlook to 2028
-
13.1 Global Gabapentin Drug Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Gabapentin Drug Consumption Forecast (2022-2028)
-
13.2.2 Canada Gabapentin Drug Consumption Forecast (2022-2028)
-
13.2.3 Mexico Gabapentin Drug Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Gabapentin Drug Consumption Forecast (2022-2028)
-
13.3.2 UK Gabapentin Drug Consumption Forecast (2022-2028)
-
13.3.3 Spain Gabapentin Drug Consumption Forecast (2022-2028)
-
13.3.4 Belgium Gabapentin Drug Consumption Forecast (2022-2028)
-
13.3.5 France Gabapentin Drug Consumption Forecast (2022-2028)
-
13.3.6 Italy Gabapentin Drug Consumption Forecast (2022-2028)
-
13.3.7 Denmark Gabapentin Drug Consumption Forecast (2022-2028)
-
13.3.8 Finland Gabapentin Drug Consumption Forecast (2022-2028)
-
13.3.9 Norway Gabapentin Drug Consumption Forecast (2022-2028)
-
13.3.10 Sweden Gabapentin Drug Consumption Forecast (2022-2028)
-
13.3.11 Poland Gabapentin Drug Consumption Forecast (2022-2028)
-
13.3.12 Russia Gabapentin Drug Consumption Forecast (2022-2028)
-
13.3.13 Turkey Gabapentin Drug Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Gabapentin Drug Consumption Forecast (2022-2028)
-
13.4.2 Japan Gabapentin Drug Consumption Forecast (2022-2028)
-
13.4.3 India Gabapentin Drug Consumption Forecast (2022-2028)
-
13.4.4 South Korea Gabapentin Drug Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Gabapentin Drug Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Gabapentin Drug Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Gabapentin Drug Consumption Forecast (2022-2028)
-
13.4.8 Thailand Gabapentin Drug Consumption Forecast (2022-2028)
-
13.4.9 Singapore Gabapentin Drug Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Gabapentin Drug Consumption Forecast (2022-2028)
-
13.4.11 Philippines Gabapentin Drug Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Gabapentin Drug Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Gabapentin Drug Consumption Forecast (2022-2028)
-
13.5.2 Colombia Gabapentin Drug Consumption Forecast (2022-2028)
-
13.5.3 Chile Gabapentin Drug Consumption Forecast (2022-2028)
-
13.5.4 Argentina Gabapentin Drug Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Gabapentin Drug Consumption Forecast (2022-2028)
-
13.5.6 Peru Gabapentin Drug Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Gabapentin Drug Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Gabapentin Drug Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Gabapentin Drug Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Gabapentin Drug Consumption Forecast (2022-2028)
-
13.6.3 Oman Gabapentin Drug Consumption Forecast (2022-2028)
-
13.6.4 Qatar Gabapentin Drug Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Gabapentin Drug Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Gabapentin Drug Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Gabapentin Drug Consumption Forecast (2022-2028)
-
13.7.2 South Africa Gabapentin Drug Consumption Forecast (2022-2028)
-
13.7.3 Egypt Gabapentin Drug Consumption Forecast (2022-2028)
-
13.7.4 Algeria Gabapentin Drug Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Gabapentin Drug Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Gabapentin Drug Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Gabapentin Drug
-
Figure of Gabapentin Drug Picture
-
Table Global Gabapentin Drug Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Gabapentin Drug Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Capsule Consumption and Growth Rate (2017-2022)
-
Figure Global Tablet Consumption and Growth Rate (2017-2022)
-
Figure Global Oral solution Consumption and Growth Rate (2017-2022)
-
Figure Global Postherpetic neuralgia in adults Consumption and Growth Rate (2017-2022)
-
Figure Global Partial onset seizures Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Gabapentin Drug Consumption by Country (2017-2022)
-
Table North America Gabapentin Drug Consumption by Country (2017-2022)
-
Figure United States Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Figure Canada Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Figure Mexico Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Gabapentin Drug Consumption by Country (2017-2022)
-
Figure Germany Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Figure UK Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Figure Spain Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Figure Belgium Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Figure France Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Figure Italy Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Figure Denmark Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Figure Finland Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Figure Norway Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Figure Sweden Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Figure Poland Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Figure Russia Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Figure Turkey Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Table APAC Gabapentin Drug Consumption by Country (2017-2022)
-
Figure China Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Figure India Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Figure Thailand Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Figure Singapore Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Figure Philippines Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Table South America Gabapentin Drug Consumption by Country (2017-2022)
-
Figure Brazil Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Figure Colombia Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Figure Chile Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Figure Argentina Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Figure Peru Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Table GCC Gabapentin Drug Consumption by Country (2017-2022)
-
Figure Bahrain Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Figure Oman Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Figure Qatar Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Table Africa Gabapentin Drug Consumption by Country (2017-2022)
-
Figure Nigeria Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Figure South Africa Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Figure Egypt Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Figure Algeria Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Table Oceania Gabapentin Drug Consumption by Country (2017-2022)
-
Figure Australia Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Gabapentin Drug Consumption and Growth Rate (2017-2022)
-
Table Jiangsu Hengrui Medicine Company Details
-
Table Jiangsu Hengrui Medicine Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Jiangsu Hengrui Medicine Gabapentin Drug Main Business and Markets Served
-
Table Jiangsu Hengrui Medicine Gabapentin Drug Product Portfolio
-
Table Depomed Company Details
-
Table Depomed Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Depomed Gabapentin Drug Main Business and Markets Served
-
Table Depomed Gabapentin Drug Product Portfolio
-
Table Sciegen Pharmaceuticals Company Details
-
Table Sciegen Pharmaceuticals Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sciegen Pharmaceuticals Gabapentin Drug Main Business and Markets Served
-
Table Sciegen Pharmaceuticals Gabapentin Drug Product Portfolio
-
Table Glenmark Company Details
-
Table Glenmark Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Glenmark Gabapentin Drug Main Business and Markets Served
-
Table Glenmark Gabapentin Drug Product Portfolio
-
Table Taro Company Details
-
Table Taro Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Taro Gabapentin Drug Main Business and Markets Served
-
Table Taro Gabapentin Drug Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Gabapentin Drug Main Business and Markets Served
-
Table Pfizer Gabapentin Drug Product Portfolio
-
Table Teva Company Details
-
Table Teva Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Gabapentin Drug Main Business and Markets Served
-
Table Teva Gabapentin Drug Product Portfolio
-
Table Amneal Pharmaceuticals Company Details
-
Table Amneal Pharmaceuticals Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amneal Pharmaceuticals Gabapentin Drug Main Business and Markets Served
-
Table Amneal Pharmaceuticals Gabapentin Drug Product Portfolio
-
Table Sun Pharmaceutical Company Details
-
Table Sun Pharmaceutical Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sun Pharmaceutical Gabapentin Drug Main Business and Markets Served
-
Table Sun Pharmaceutical Gabapentin Drug Product Portfolio
-
Table Aurobindo Pharma Company Details
-
Table Aurobindo Pharma Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aurobindo Pharma Gabapentin Drug Main Business and Markets Served
-
Table Aurobindo Pharma Gabapentin Drug Product Portfolio
-
Table Tris Pharma Company Details
-
Table Tris Pharma Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tris Pharma Gabapentin Drug Main Business and Markets Served
-
Table Tris Pharma Gabapentin Drug Product Portfolio
-
Table Epic Pharma Company Details
-
Table Epic Pharma Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Epic Pharma Gabapentin Drug Main Business and Markets Served
-
Table Epic Pharma Gabapentin Drug Product Portfolio
-
Table Lupin Limited Company Details
-
Table Lupin Limited Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lupin Limited Gabapentin Drug Main Business and Markets Served
-
Table Lupin Limited Gabapentin Drug Product Portfolio
-
Table Acella Pharmaceuticals Company Details
-
Table Acella Pharmaceuticals Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Acella Pharmaceuticals Gabapentin Drug Main Business and Markets Served
-
Table Acella Pharmaceuticals Gabapentin Drug Product Portfolio
-
Table Marksans Pharma Company Details
-
Table Marksans Pharma Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Marksans Pharma Gabapentin Drug Main Business and Markets Served
-
Table Marksans Pharma Gabapentin Drug Product Portfolio
-
Table ACI HealthCare Limited Company Details
-
Table ACI HealthCare Limited Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table ACI HealthCare Limited Gabapentin Drug Main Business and Markets Served
-
Table ACI HealthCare Limited Gabapentin Drug Product Portfolio
-
Table InvaGen Pharmaceuticals Company Details
-
Table InvaGen Pharmaceuticals Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table InvaGen Pharmaceuticals Gabapentin Drug Main Business and Markets Served
-
Table InvaGen Pharmaceuticals Gabapentin Drug Product Portfolio
-
Table CSPC Ouyi Pharmaceutical Company Details
-
Table CSPC Ouyi Pharmaceutical Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table CSPC Ouyi Pharmaceutical Gabapentin Drug Main Business and Markets Served
-
Table CSPC Ouyi Pharmaceutical Gabapentin Drug Product Portfolio
-
Table Apotex Company Details
-
Table Apotex Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Apotex Gabapentin Drug Main Business and Markets Served
-
Table Apotex Gabapentin Drug Product Portfolio
-
Table Alkem Laboratories Company Details
-
Table Alkem Laboratories Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alkem Laboratories Gabapentin Drug Main Business and Markets Served
-
Table Alkem Laboratories Gabapentin Drug Product Portfolio
-
Table Mylan Company Details
-
Table Mylan Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Gabapentin Drug Main Business and Markets Served
-
Table Mylan Gabapentin Drug Product Portfolio
-
Table Zydus Pharmaceuticals Company Details
-
Table Zydus Pharmaceuticals Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zydus Pharmaceuticals Gabapentin Drug Main Business and Markets Served
-
Table Zydus Pharmaceuticals Gabapentin Drug Product Portfolio
-
Table Hi-Tech Pharmaceuticals Company Details
-
Table Hi-Tech Pharmaceuticals Gabapentin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hi-Tech Pharmaceuticals Gabapentin Drug Main Business and Markets Served
-
Table Hi-Tech Pharmaceuticals Gabapentin Drug Product Portfolio
-
Figure Global Capsule Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tablet Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral solution Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Postherpetic neuralgia in adults Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Partial onset seizures Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gabapentin Drug Consumption Forecast by Country (2022-2028)
-
Table North America Gabapentin Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Gabapentin Drug Consumption Forecast by Country (2022-2028)
-
Figure Germany Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Gabapentin Drug Consumption Forecast by Country (2022-2028)
-
Figure China Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Gabapentin Drug Consumption Forecast by Country (2022-2028)
-
Figure Brazil Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Gabapentin Drug Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Gabapentin Drug Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Gabapentin Drug Consumption Forecast by Country (2022-2028)
-
Figure Australia Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Gabapentin Drug Consumption Forecast and Growth Rate (2022-2028)
-
